Aucun résultat
Dr. Shireen Sirhan co-established the first Myeloproliferative Neoplasms (MPN) clinic in Canada at the Jewish General Hospital, where specialized multidisciplinary care and access to specialised testing and clinical trials is offered. She is the principal investigator on several clinical trials that have helped providing access to novel agents in the field of MPNs.
She is a founding member and the current President of the Canadian MPN group, and Vice-President for research in MPNs of the Groupe Québécois de recherche en LMC-NMP. She also serves as member of advisory board for Canadian MPN Research Foundation.
Research interests include:
